140 related articles for article (PubMed ID: 30093116)
1. Lysophosphatidic acid receptor-2 (LPA
Takahashi K; Minami K; Otagaki S; Ishimoto K; Fukushima K; Fukushima N; Honoki K; Tsujiuchi T
Biochem Biophys Res Commun; 2018 Sep; 503(4):2698-2703. PubMed ID: 30093116
[TBL] [Abstract][Full Text] [Related]
2. Enhanced cellular functions through induction of LPA
Takahashi K; Fukushima K; Fukushima N; Honoki K; Tsujiuchi T
Mol Cell Biochem; 2017 Jul; 431(1-2):29-35. PubMed ID: 28205098
[TBL] [Abstract][Full Text] [Related]
3. Cooperation of G12/13 and Gi proteins via lysophosphatidic acid receptor-2 (LPA
Minami K; Ueda N; Ishimoto K; Kurisu R; Takamoto M; Ikeda H; Tsujiuchi T
Biochem Biophys Res Commun; 2020 Nov; 532(3):427-432. PubMed ID: 32883524
[TBL] [Abstract][Full Text] [Related]
4. Modulation of chemoresistance by lysophosphatidic acid (LPA) signaling through LPA
Minami K; Ueda N; Maeda H; Ishimoto K; Otagaki S; Tsujiuchi T
Biochem Biophys Res Commun; 2019 Sep; 517(2):359-363. PubMed ID: 31362892
[TBL] [Abstract][Full Text] [Related]
5. LPA
Minami K; Ueda N; Ishimoto K; Tsujiuchi T
Exp Cell Res; 2020 Mar; 388(1):111813. PubMed ID: 31904382
[TBL] [Abstract][Full Text] [Related]
6. Lysophosphatidic acid signaling via LPA
Fukushima K; Takahashi K; Yamasaki E; Onishi Y; Fukushima N; Honoki K; Tsujiuchi T
Exp Cell Res; 2017 Mar; 352(1):139-145. PubMed ID: 28189636
[TBL] [Abstract][Full Text] [Related]
7. Involvement of LPA signaling via LPA receptor-2 in the promotion of malignant properties in osteosarcoma cells.
Takahashi K; Fukushima K; Tanaka K; Minami K; Ishimoto K; Otagaki S; Fukushima N; Honoki K; Tsujiuchi T
Exp Cell Res; 2018 Aug; 369(2):316-324. PubMed ID: 29859140
[TBL] [Abstract][Full Text] [Related]
8. Lysophosphatidic acid receptor-2 (LPA
Minami K; Ueda N; Ishimoto K; Tsujiuchi T
Mol Cell Biochem; 2020 Jun; 469(1-2):89-95. PubMed ID: 32301060
[TBL] [Abstract][Full Text] [Related]
9. Involvement of LPA receptor-5 in the enhancement of cell motile activity by phorbol ester and anticancer drug treatments in melanoma A375 cells.
Fukushima K; Takahashi K; Kurokawa A; Ishimoto K; Otagaki S; Minami K; Fukushima N; Honoki K; Tsujiuchi T
Biochem Biophys Res Commun; 2018 Jan; 496(1):225-230. PubMed ID: 29309788
[TBL] [Abstract][Full Text] [Related]
10. Effects of lysophosphatidic acid (LPA) receptor-2 (LPA
Ueda N; Minami K; Ishimoto K; Tsujiuchi T
Cell Signal; 2020 May; 69():109551. PubMed ID: 32006610
[TBL] [Abstract][Full Text] [Related]
11. LPA signaling through LPA receptors regulates cellular functions of endothelial cells treated with anticancer drugs.
Mori S; Araki M; Ishii S; Hirane M; Fukushima K; Tomimatsu A; Takahashi K; Fukushima N; Tsujiuchi T
Mol Cell Biochem; 2015 Oct; 408(1-2):147-54. PubMed ID: 26116018
[TBL] [Abstract][Full Text] [Related]
12. Promotion of cell-invasive activity through the induction of LPA receptor-1 in pancreatic cancer cells.
Fukushima K; Otagaki S; Takahashi K; Minami K; Ishimoto K; Fukushima N; Honoki K; Tsujiuchi T
J Recept Signal Transduct Res; 2018 Aug; 38(4):367-371. PubMed ID: 30396320
[TBL] [Abstract][Full Text] [Related]
13. Roles of endothelial cells in the regulation of cell motility via lysophosphatidic acid receptor-2 (LPA
Minami K; Ueda N; Ishimoto K; Kurisu R; Takamoto M; Ikeda H; Tsujiuchi T
Exp Mol Pathol; 2021 Feb; 118():104596. PubMed ID: 33347862
[TBL] [Abstract][Full Text] [Related]
14. Regulation of cellular responses to X-ray irradiation through the activation of lysophosphatidic acid (LPA) receptor-3 (LPA
Ikeda H; Takai M; Yashiro N; Amano Y; Hara K; Yamamoto M; Tsujiuchi T
Pathol Res Pract; 2024 May; 257():155293. PubMed ID: 38615508
[TBL] [Abstract][Full Text] [Related]
15. Different effects of lysophosphatidic acid receptor-2 (LPA
Ishimoto K; Minami A; Minami K; Ueda N; Tsujiuchi T
J Recept Signal Transduct Res; 2021 Feb; 41(1):93-98. PubMed ID: 32672083
[TBL] [Abstract][Full Text] [Related]
16. Effects of lysophosphatidic acid (LPA) signaling via LPA receptors on cellular functions associated with ATP reduction in osteosarcoma cells treated with ethidium bromide.
Kurisu R; Takamoto M; Minami K; Ueda N; Yamada M; Shima N; Otani T; Sakai Y; Kondo D; Tsujiuchi T
J Bioenerg Biomembr; 2022 Apr; 54(2):109-117. PubMed ID: 35260987
[TBL] [Abstract][Full Text] [Related]
17. Negative effects of G-protein-coupled free fatty acid receptor GPR40 on cell migration and invasion in fibrosarcoma HT1080 cells.
Ishii S; Kitamura Y; Hirane M; Tomimatsu A; Fukushima K; Takahashi K; Fukushima N; Honoki K; Tsujiuchi T
Mol Carcinog; 2016 Nov; 55(11):1553-1559. PubMed ID: 26331585
[TBL] [Abstract][Full Text] [Related]
18. Effects of LPA
Takahashi K; Fukushima K; Otagaki S; Ishimoto K; Minami K; Fukushima N; Honoki K; Tsujiuchi T
J Recept Signal Transduct Res; 2018 Feb; 38(1):71-75. PubMed ID: 29369010
[TBL] [Abstract][Full Text] [Related]
19. Lysophosphatidic acid receptor-5 negatively regulates cell motile and invasive activities of human sarcoma cell lines.
Dong Y; Hirane M; Araki M; Fukushima N; Honoki K; Tsujiuchi T
Mol Cell Biochem; 2014 Aug; 393(1-2):17-22. PubMed ID: 24676544
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effects of lysophosphatidic acid receptor-5 on cellular functions of sarcoma cells.
Araki M; Kitayoshi M; Dong Y; Hirane M; Ozaki S; Mori S; Fukushima N; Honoki K; Tsujiuchi T
Growth Factors; 2014 Jun; 32(3-4):117-22. PubMed ID: 24798396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
